Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics
出版年份 2014 全文链接
标题
Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics
作者
关键词
-
出版物
BRITISH JOURNAL OF HAEMATOLOGY
Volume 169, Issue 2, Pages 228-240
出版商
Wiley
发表日期
2014-11-29
DOI
10.1111/bjh.13240
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Inhibition of GTPase Rac1 in Endothelium by 6-Mercaptopurine Results in Immunosuppression in Nonimmune Cells: New Target for an Old Drug
- (2014) G. Marinkovi et al. JOURNAL OF IMMUNOLOGY
- Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: Influence on cure rates and risk of second cancer
- (2014) Mette Levinsen et al. PEDIATRIC BLOOD & CANCER
- Thiopurine pharmacogenomics: association of SNPs with clinical response and functional validation of candidate genes
- (2014) Alice Matimba et al. PHARMACOGENOMICS
- Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: A systematic review
- (2013) M. Verbrugghe et al. CANCER TREATMENT REVIEWS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update
- (2013) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial
- (2013) Ajay Vora et al. LANCET ONCOLOGY
- Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia
- (2012) Lynne Lennard et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Nonadherence to Oral Mercaptopurine and Risk of Relapse in Hispanic and Non-Hispanic White Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
- (2012) Smita Bhatia et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing
- (2011) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Thiopurine S-methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6-mercaptopurine doses during maintenance therapy: The Polish multicenter analysis
- (2011) Jarosław Peregud-Pogorzelski et al. PEDIATRIC BLOOD & CANCER
- Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Munster protocols
- (2009) M. Stanulla et al. BLOOD
- Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study
- (2009) K. Schmiegelow et al. BLOOD
- The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99
- (2009) Christopher Mitchell et al. BRITISH JOURNAL OF HAEMATOLOGY
- Heterozygosity at the TPMT gene locus, augmented by mutated MTHFR gene, predisposes to 6-MP related toxicities in childhood ALL patients
- (2008) N Karas-Kuzelicki et al. LEUKEMIA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started